Appointment booking for Dr. Clayton Chang, MD is currently not available.Dr. Clayton Chang, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Clayton Chang, MD is a Internist in Pottstown, PA with over 18 years of experience. What is your opinion of Dr. Clayton Chang, MD? Rate this provider below so other people can make informed decision.
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Clayton Chang, MD has received over $3,631 which includes payments from the following companies:
$1,007.11 from Novo Nordisk Inc
$363.94 from AstraZeneca Pharmaceuticals LP
$263.78 from Amgen Inc.
$260.65 from GlaxoSmithKline, LLC.
$247.79 from Astellas Pharma US Inc
$200.90 from Merck Sharp & Dohme Corporation
$161.83 from Sanofi Pasteur Inc.
$159.01 from LILLY USA, LLC
$127.24 from sanofi-aventis U.S. LLC
$118.40 from Teva Pharmaceuticals USA, Inc.
$81.77 from Allergan Inc.
$81.66 from Janssen Pharmaceuticals, Inc
$81.51 from Actavis Pharma Inc
$49.35 from Boehringer Ingelheim Pharmaceuticals, Inc.
$47.85 from US WorldMeds, LLC
$38.46 from Purdue Pharma L.P.
$38.22 from Mylan Specialty L.P.
$36.58 from Horizon Pharma plc
$30.65 from Celgene Corporation
$29.93 from Boston Scientific Corporation
Payments received by Dr. Clayton Chang, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!